Putnam BioRevolution ETF Rating $30.31 +0.24 (+0.80%) Closing price 04:10 PM EasternExtended Trading$30.31 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsBuy This Stock Putnam BioRevolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SYNB Aggregate RatingModerate Buy 2.78Holdings in SYNB have an aggregate rating of Moderate Buy based on 346 analyst ratings issued in the past year covering 21 companies (80.7% of the portfolio).SYNB Aggregate Price Target$30.07-0.79% DownsideHigh Prediction$30.07Average Prediction$30.07Low Prediction$30.07Holdings in SYNB have an aggregate price target of $30.07 and a range of $30.07 to $30.07 covering 21 companies (80.7% of the portfolio).SYNB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Putnam BioRevolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 SYNB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.15%TMOThermo Fisher Scientific$497.94+2.1%4.929 of 5 stars2.73$593.00 19.1%22Trending NewsAnalyst Forecast5.98%CTVACorteva$72.32+0.0%4.6922 of 5 stars2.87$80.25 11.0%15Positive News5.20%NVZMYNovozymes A/S$65.53+1.0%3.4895 of 5 stars3.003Upcoming Earnings5.15%ABBVAbbVie$205.99-0.3%4.7296 of 5 stars2.96$214.95 4.3%27Trending News4.79%NVDANVIDIA$175.64-3.5%4.6025 of 5 stars2.93$189.28 7.8%42Trending NewsAnalyst ForecastInsider Trade4.62%ASNDAscendis Pharma A/S$194.62+0.3%2.0562 of 5 stars3.00$243.36 25.0%15Analyst Forecast4.46%BIOBio-Rad Laboratories$286.93+0.8%4.4933 of 5 stars2.75$333.50 16.2%4Positive News4.38%AZNAstraZeneca$79.54+0.5%2.9147 of 5 stars2.80$86.00 8.1%5Positive News4.05%CDNSCadence Design Systems$346.88-2.6%4.1845 of 5 stars2.73$364.33 5.0%15Positive NewsShort Interest ↑3.53%ICLRIcon$179.64+0.6%4.2796 of 5 stars2.81$219.54 22.2%163.36%DDDuPont de Nemours$73.67+0.7%4.4134 of 5 stars2.75$88.25 19.8%12Positive News3.34%ZTSZoetis$155.52+2.1%4.9077 of 5 stars2.50$202.43 30.2%8News CoveragePositive News3.22%DHRDanaher$212.24+1.5%4.7375 of 5 stars2.85$247.61 16.7%20Positive News3.14%LLYEli Lilly and Company$703.57+0.8%4.9993 of 5 stars2.65$950.17 35.0%23Trending NewsAnalyst Downgrade3.07%REGNRegeneron Pharmaceuticals$571.78-0.4%4.8709 of 5 stars2.81$829.65 45.1%26Positive NewsDividend Announcement2.90%NGVTIngevity$55.19-0.3%1.8923 of 5 stars2.50$55.00 -0.3%22.64%DARDarling Ingredients$30.99-0.1%4.7048 of 5 stars2.78$45.86 48.0%9Positive News2.51%TECHBio-Techne$54.87+3.0%4.9496 of 5 stars2.62$69.42 26.5%13Positive NewsDividend Announcement2.16%AVTRAvantor$13.00+1.8%4.6878 of 5 stars2.47$15.50 19.3%15Positive News2.09%BIIBBiogen$138.86+2.2%4.8559 of 5 stars2.34$185.74 33.8%32Analyst Revision1.91%ONONON$45.00-0.5%4.002 of 5 stars2.91$64.20 42.7%22 This page (NYSEARCA:SYNB) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access